» Articles » PMID: 19157856

Prion Protein Misfolding and Disease

Overview
Date 2009 Jan 23
PMID 19157856
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Transmissible spongiform encephalopathies (TSEs or prion diseases) are a rare group of invariably fatal neurodegenerative disorders that affect humans and other mammals. TSEs are protein misfolding diseases that involve the accumulation of an abnormally aggregated form of the normal host prion protein (PrP). They are unique among protein misfolding disorders in that they are transmissible and have different strains of infectious agents that are associated with unique phenotypes in vivo. A wealth of biological and biophysical evidence now suggests that the molecular basis for prion diseases may be encoded by protein conformation. The purpose of this review is to provide an overview of the existing structural information for PrP within the context of what is known about the biology of prion disease.

Citing Articles

Prion-like Spreading of Disease in TDP-43 Proteinopathies.

Pongracova E, Buratti E, Romano M Brain Sci. 2024; 14(11).

PMID: 39595895 PMC: 11591745. DOI: 10.3390/brainsci14111132.


Assessment of the therapeutic potential of Hsp70 activator against prion diseases using and models.

Zayed M, Kim Y, Jeong B Front Cell Dev Biol. 2024; 12:1411529.

PMID: 39105172 PMC: 11298377. DOI: 10.3389/fcell.2024.1411529.


Detecting anomalous proteins using deep representations.

Michael-Pitschaze T, Cohen N, Ofer D, Hoshen Y, Linial M NAR Genom Bioinform. 2024; 6(1):lqae021.

PMID: 38486884 PMC: 10939404. DOI: 10.1093/nargab/lqae021.


Prion-Like Proteins in Phase Separation and Their Link to Disease.

Sprunger M, Jackrel M Biomolecules. 2021; 11(7).

PMID: 34356638 PMC: 8301953. DOI: 10.3390/biom11071014.


The N-terminus of an Ustilaginoidea virens Ser-Thr-rich glycosylphosphatidylinositol-anchored protein elicits plant immunity as a MAMP.

Song T, Zhang Y, Zhang Q, Zhang X, Shen D, Yu J Nat Commun. 2021; 12(1):2451.

PMID: 33907187 PMC: 8079714. DOI: 10.1038/s41467-021-22660-9.


References
1.
Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K . NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 1997; 413(2):282-8. DOI: 10.1016/s0014-5793(97)00920-4. View

2.
Lu X, Wintrode P, Surewicz W . Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci U S A. 2007; 104(5):1510-5. PMC: 1785245. DOI: 10.1073/pnas.0608447104. View

3.
Castilla J, Saa P, Hetz C, Soto C . In vitro generation of infectious scrapie prions. Cell. 2005; 121(2):195-206. DOI: 10.1016/j.cell.2005.02.011. View

4.
Kundu B, Maiti N, Jones E, Surewicz K, Vanik D, Surewicz W . Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Proc Natl Acad Sci U S A. 2003; 100(21):12069-74. PMC: 218714. DOI: 10.1073/pnas.2033281100. View

5.
DeMarco M, Daggett V . From conversion to aggregation: protofibril formation of the prion protein. Proc Natl Acad Sci U S A. 2004; 101(8):2293-8. PMC: 356944. DOI: 10.1073/pnas.0307178101. View